Brasília – Experts raised the alarm about the urgent need for faster responses to cancer in Brazil, stressing that prevention, early diagnosis, and expanded access to treatment must be prioritized.

According to data from the National Cancer Institute (INCA), approximately 704,000 new cancer cases per year are expected nationwide in the period 2023–2025, with skin (non-melanoma), breast, prostate, colorectal, lung, and stomach cancers being the most prevalent. Early diagnosis plays a critical role: the Society of Clinical Oncology (SBOC) emphasizes that many cancers, when detected early, offer high chances of cure.

Although Law 13.896/19 mandates that suspected cancer cases in the public system must undergo diagnostic testing within 30 days, and treatment must begin within 60 days of diagnosis, many patients encounter delays at each stage of the care continuum. A 2020 study published in The British Medical Journal found that each four-week delay in cancer treatment can increase the risk of death by up to 13%.

Experts are hopeful that the new administration will prioritize oncology and ensure the incorporation and implementation of innovative therapies across Brazil’s health system.

Source: O Estado de S.Paulo

Would you like a complete analysis on this? Contact us at pharmabrnews@gmail.com